NCT06162325View on ClinicalTrials.gov

Venetoclax in Combination With Standard Induction and Consolidation Chemotherapy in Newly Diagnosed Young AML Patients

Enrolling by invitationOBSERVATIONAL

Enrollment

45

Participants

Timeline

Start Date

January 21, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions

Acute Myeloid Leukemia

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors

lead

Peking Union Medical College Hospital

OTHER